Inventor · disambiguated record
Markus Muenz
Also filed as: MUENZ MARKUS
5 granted patents·10 pending applications·19 citations·filing 2006–2025
73Inventor score
Top patents by PatentIndex Score
15 records- 0193US10519241B2Antibody constructs for EGFRVIII and CD3AMGEN RES MUNICH GMBH·Filed 2016·Granted Dec 31, 2019·16 cites·22 claims
- 0286US11155629B2Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3AMGEN RES MUNICH GMBH·Filed 2019·Granted Oct 26, 2021·2 cites·20 claims
- 0375US12152078B2Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3AMGEN RES MUNICH GMBH·Filed 2021·Granted Nov 26, 2024·0 cites·24 claims
- 0472US2023057728A1Long life polypeptide binding moleculesAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 0570US9505849B2Antibody constructs for influenza M2 and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Nov 29, 2016·1 cites·20 claims
- 0668US2025163177A1Bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 0762US2025333536A1Mageb2 binding constructsAMGEN INC·Filed 2025·Application pending·0 cites
- 0858US12312412B2MAGEB2 binding constructsAMGEN INC·Filed 2021·Granted May 27, 2025·0 cites·11 claims
- 0955US2024209078A1Multitargeting bispecific antigen-binding molecules of increased selectivityAMGEN INC·Filed 2021·Application pending·0 cites
- 1054US2015037334A1Long life polypeptide binding moleculesAMGEN RES MUNICH GMBH·Filed 2013·Application pending·0 cites
- 1153US2023406929A1Polypeptide constructs binding to cd3AMGEN INC·Filed 2021·Application pending·0 cites
- 1251US2023406887A1Antigen binding domain with reduced clipping rateAMEGEN INC·Filed 2021·Application pending·0 cites
- 1347US2022403035A1Multitargeting antigen-binding molecules for use in proliferative diseasesAMGEN RES MUNICH GMBH·Filed 2020·Application pending·0 cites
- 1441US2007009501A1Squamous cell carcinoma antigens and use thereforGIRES OLIVER·Filed 2006·Application pending·0 cites
- 1530US2010226922A1Specific protease inhibitors and their use in cancer therapyMAETZEL DOROTHEA·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Muenz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →